bruising from glp 1 injection Bruise at Site : r/Zepbound New Analysis Clarifies the Dermatologic

Muller TD, Clemmensen C, Finan B, DiMarchi RD, Tschop MH

2022 Oct 1;28(10):208391

Berendsen, H

The injectable obesity medications Semaglutide 2.4 mg, a selective GLP-1 receptor agonist, produces robust and durable weight loss of approximately 1516% over 68 weeks ( Tirzepatide, a dual gastric inhibitory polypeptide (GIP)/GLP-1 receptor agonist, delivers even greater weight loss, exceeding 20% at the highest dose in pivotal trials ( Retatrutide, a triple agonist targeting GIP, GLP-1, and glucagon receptors, represents a further step in efficacy, with 24.2% weight loss achieved within 48 weeks in phase 2 studies ( Survodutide, an oxyntomodulin analogue, achieved clinically meaningful weight loss ( Table 2

This study, for the first time, proved cardioprotective effect of GLP-1 in rat hearts and gave the foundation for exploring new theraputical potential of GLP-1 agonists